Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Sudarshan

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|August 20, 2025
The mevalonate pathway couples lipid metabolism to amino acid synthesis via ubiquinone-dependent redox controlThi Thinh Nguyen, Mohit Bansal, Jane Ding, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
DKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptationAnamika Gupta, Mohit Bansal, Jane Ding, et al.
The Indian Journal of Surgery|December 4, 2012
Strangulated Richter's Umbilical Hernia - A Case ReportJohn J S Martis, K V Rajeshwara, M Kalpana Shridhar, et al.
The Journal of Urology|May 20, 2008
Feasibility and outcomes of repeat partial nephrectomyAaron Johnson, Sunil Sudarshan, Jack Liu, et al.
The Journal of Biological Chemistry|July 17, 2014
The oncometabolite fumarate promotes pseudohypoxia through noncanonical activation of NF-κB signalingKarthigayan Shanmugasundaram, Bijaya Nayak, Eun-Hee Shim, et al.
Science Advances|August 29, 2025
DKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptationAnamika Gupta, Mohit Bansal, Jane Ding, et al.
The Journal of Urology|March 20, 2010
Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomesNick W Liu, Kiranpreet Khurana, Sunil Sudarshan, et al.
Cell Cycle (Georgetown, Tex.)|October 19, 2010
Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinomaCarole Sourbier, Vladimir Valera-Romero, Alessio Giubellino, et al.
Cancer Gene Therapy|April 8, 2003
Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expressionMarc L Hyer, Sunil Sudarshan, David A Schwartz, et al.
Cancer Gene Therapy|October 30, 2004
In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancerSunil Sudarshan, David H Holman, Marc L Hyer, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|August 20, 2025
The mevalonate pathway couples lipid metabolism to amino acid synthesis via ubiquinone-dependent redox controlThi Thinh Nguyen, Mohit Bansal, Jane Ding, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
DKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptationAnamika Gupta, Mohit Bansal, Jane Ding, et al.
The Indian Journal of Surgery|December 4, 2012
Strangulated Richter's Umbilical Hernia - A Case ReportJohn J S Martis, K V Rajeshwara, M Kalpana Shridhar, et al.
The Journal of Urology|May 20, 2008
Feasibility and outcomes of repeat partial nephrectomyAaron Johnson, Sunil Sudarshan, Jack Liu, et al.
The Journal of Biological Chemistry|July 17, 2014
The oncometabolite fumarate promotes pseudohypoxia through noncanonical activation of NF-κB signalingKarthigayan Shanmugasundaram, Bijaya Nayak, Eun-Hee Shim, et al.
Science Advances|August 29, 2025
DKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptationAnamika Gupta, Mohit Bansal, Jane Ding, et al.
The Journal of Urology|March 20, 2010
Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomesNick W Liu, Kiranpreet Khurana, Sunil Sudarshan, et al.
Cell Cycle (Georgetown, Tex.)|October 19, 2010
Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinomaCarole Sourbier, Vladimir Valera-Romero, Alessio Giubellino, et al.
Cancer Gene Therapy|April 8, 2003
Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expressionMarc L Hyer, Sunil Sudarshan, David A Schwartz, et al.
Cancer Gene Therapy|October 30, 2004
In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancerSunil Sudarshan, David H Holman, Marc L Hyer, et al.
Pageof 6